Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Enhanced Elimination of Poison01:26

Enhanced Elimination of Poison

Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kidney health for all: caring for people, protecting the planet.

Hong Kong medical journal = Xianggang yi xue za zhi·2026
Same author

Host factors dictate gut microbiome alterations in chronic kidney disease more strongly than kidney function.

Nature microbiology·2026
Same author

A Population Pharmacokinetic Analysis for Piperacillin/Tazobactam in Patients with End-Stage Kidney Disease Undergoing Intermittent Haemodialysis: Extension of a General-Purpose Model.

Clinical pharmacokinetics·2025
Same author

Wars and kidney patients: a statement by the European Kidney Health Alliance related to the Russian-Ukrainian conflict.

Journal of nephrology·2022
Same author

Comparison of five assays for DNA extraction from bacterial cells in human faecal samples.

Journal of applied microbiology·2020
Same author

White noise speech illusions in the general population: The association with psychosis expression and risk factors for psychosis.

PloS one·2019

Related Experiment Video

Updated: May 19, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

An update on uremic toxins.

N Neirynck1, R Vanholder, E Schepers

  • 1Nephrology Section, 0K12, Department of Internal Medicine, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium.

International Urology and Nephrology
|August 16, 2012
PubMed
Summary
This summary is machine-generated.

Uremic toxins contribute to cardiovascular disease in chronic kidney disease patients. Current dialysis methods struggle to remove many of these toxins, necessitating further research into alternative strategies for improved patient outcomes.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

Related Experiment Videos

Last Updated: May 19, 2026

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions
06:32

Development of Human Renal Tubular Epithelial Cell Primary Cultures in Monolayers and Three-Dimensional Conditions

Published on: June 13, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

Area of Science:

  • Nephrology
  • Cardiology
  • Toxicology

Background:

  • Uremic toxicity is increasingly recognized as a significant factor in the high rates of cardiovascular disease and mortality among patients with chronic kidney disease (CKD).
  • Various uremic toxins, including protein-bound solutes (e.g., indoxyl sulfate, p-cresol conjugates) and small water-soluble solutes (e.g., guanidines, ADMA, SDMA), have demonstrated cardiovascular toxicity in vitro and in vivo.
  • Middle molecules such as beta-2-microglobulin, IL-6, TNF-alpha, and FGF-23 are established predictors of cardiovascular events and mortality in CKD.

Purpose of the Study:

  • To review uremic toxins with known cardiovascular effects and discuss their removal challenges during dialysis.
  • To highlight the limitations of conventional dialysis in clearing diverse uremic toxins beyond urea.
  • To explore and evaluate alternative strategies for enhancing the removal of detrimental uremic solutes.

Main Methods:

  • Literature review focusing on uremic toxins, their cardiovascular impact, and dialysis removal efficiency.
  • Analysis of in vitro and in vivo studies investigating the mechanisms of uremic toxin-induced cardiovascular damage.
  • Evaluation of different dialysis membrane characteristics (pore size) and techniques (convection, diffusion, dialysis time) for solute removal.
  • Exploration of non-dialytic removal strategies and their potential clinical applications.

Main Results:

  • Protein-bound solutes and certain small water-soluble toxins play a role in cardiovascular toxicity.
  • Many uremic toxins, particularly middle molecules and protein-bound solutes, are poorly removed by conventional hemodialysis, which primarily assesses urea clearance.
  • Enhanced removal of middle molecules is achieved with larger pore membranes, increased convection, and prolonged dialysis.
  • Convection, in addition to diffusion, is crucial for improving the removal of protein-bound toxins.

Conclusions:

  • Standard dialysis is insufficient for removing a broad spectrum of cardiovascularly toxic uremic solutes.
  • Novel strategies including intestinal adsorption, pharmacologic interventions, plasma adsorption, and optimized dialysis kinetics require further investigation.
  • Randomized clinical trials are essential to validate the efficacy of these alternative strategies and demonstrate a survival benefit in CKD patients.